Alterity Therapeutics Limited | PRAN - Operating Expenses


Alterity Therapeutics Limited reported AUD7.78M in Operating Expenses for its fiscal semester ending in June of 2023.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 7.78M 3M Jun/2023
Arca Biopharma USD 25.09M 5.23M Mar/2025
aTyr Pharma USD 26.94M 6.63M Sep/2025
Bio Path USD 3.24M 616K Mar/2025
Brainstorm Cell Therapeutics USD 3.09M 100K Mar/2025
Capricor Therapeutics USD 24.98M 6.15M Mar/2025
Cara Therapeutics USD 4.96M 2.38M Mar/2025
CSL USD 5.7B 2.82B Dec/2025
Esperion Therapeutics USD 67.66M 3.6M Sep/2024
Immunic USD 25.73M 2.91M Sep/2024
Infinity Pharmaceuticals USD 10.7M 1.54M Jun/2023
Insmed USD 513.55M 109.86M Dec/2025
Minerva Neurosciences USD 4.52M 155.46K Dec/2024
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
TherapeuticsMD USD 1.41M 50K Jun/2024